UnitedHealth Group Incorporated (UNH)
The Zacks Analyst Blog UnitedHealth, SAP, Toyota and Better Choice
UnitedHealth, SAP, Toyota and Better Choice are included in this Analyst Blog.
Here is What to Know Beyond Why UnitedHealth Group Incorporated (UNH) is a Trending Stock
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
UnitedHealth wins favorable ruling against US fraud case
A court-appointed special master has found that U.S. authorities do not have evidence to support their billion-dollar fraud case accusing UnitedHealth Group of keeping overpayments from the government for patients on its Medicare insurance plans.
UnitedHealth gains on Medicare fraud case finding win
UnitedHealth Group Inc ticked up on Tuesday after winning a favourable finding in a long-running case against the Department of Justice over alleged Medicare fraud. A special master overseeing collection of evidence recommended rejecting the case, in which UnitedHealth is claimed to have overbilled Medicare by at least $2.1 billion.
Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Sen. Grassley launches inquiry into UnitedHealth Group's Medicare billing practices, WSJ reports
U.S. Senator Chuck Grassley has sent a letter to UnitedHealth CEO Andrew Witty on Monday demanding detailed information on the company's Medicare billing practices, the Wall Street Journal reported.
UnitedHealth Group (UNH) Sees a More Significant Dip Than Broader Market: Some Facts to Know
UnitedHealth Group (UNH) closed at $461.52 in the latest trading session, marking a -1.05% move from the prior day.
UnitedHealth's RSI Suggests It Is Extremely Oversold
Few stocks get this oversold this quickly, especially mega-cap names like UnitedHealth Group Inc. NYSE: UNH. After a 45% rally from March into December, the stock has now collapsed 30%, sending it back to multi-year lows.
UnitedHealth: Well Oversold And Undervalued, Despite Significant Headwinds
UnitedHealth Group faces unconfirmed allegations of inflating risk ratings for reimbursements, causing market panic despite no DOJ confirmation or filed charges. UNH's diversified business model and robust forward guidance suggest the market has likely overreacted to these headwinds. UNH's valuation is arguably undervalued now, while its price action suggests a strong support zone is in place for dip buyers.
UnitedHealth Group stock price takes another tumble on report of alleged DOJ Medicare billing probe
UnitedHealth Group, America's largest insurer, is facing yet another crisis. The company's stock price (NYSE: UNH) plummeted in early trading this morning after a new report alleged that the private insurance provider is facing a probe from the U.S. Department of Justice (DOJ) over its Medicare billing practices, a claim UnitedHealth Group denies.
Raymond James' John Ransom explains why his is sticking with 'strong buy' rating for UnitedHealth
John Ransom, Raymond James, joins 'Fast Money' to talk why he is still optimistic on UnitedHealth despite DOJ probe.
I'd buy more of UnitedHealth today, says Hightower's Stephanie Link
Stephanie Link, Hightower Advisors, joins 'Closing Bell' to discuss the DOJ probe into UnitedHealth and its impact on the stock.
